icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
ITPA gene variants predict haemolytic ribavirin-induced anaemia in patients treated with the interferon-free regimen of faldaprevir, BI 207127 and ribavirin in SOUND-C2
 
 
  Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
 
Tarik Asselah,1 Stefan Zeuzem,2 Vicente Soriano,3 Jean-Pierre Bronowicki,4 Ansgar W. Lohse,5 Beat Mullhaupt,6 Marcus Schuchmann,7 Marc Bourliere,8 Maria Buti,9 Stuart Roberts,10 Ed Gane,11 Jerry O Stern,12 Patrick Baum,13 Florian Voss,13 John-Paul Gallivan,14 Wulf Bocher,14 Federico J Mensa12
1Hopital Beaujon, Clichy, France; 2Klinikum der J. W. Goethe-Universitšt, Frankfurt am Main, Germany; 3Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain; 4Hopital de Brabois, Vandoeuvre, France; 5University Hospital Hamburg-Eppendorf, Hamburg, Germany; 6University Hospital of Zurich, Zurich, Switzerland; 7University Hospital Mainz, Mainz, Germany; 8Hopital Saint Joseph, Marseille, France;
9Hospital Vall d'Hebron and Ciberehd, Barcelona, Spain; 10Alfred Hospital, Department of Gastroenterology, Melbourne, Australia; 11Auckland Clinical Studies, Auckland, New Zealand; 12Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA; 13Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; 14Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif